Emerging Infections Programs (EIP)
Expiration Date: 04/30/2022
Non-Substantive Change Request
Program Contact
Sandra Bulens
Healthcare-Associated Infections/Community Interface (HAIC)/ Emerging Infections Program (EIP)
Division of Healthcare Quality Promotion
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd,
Atlanta, GA 30329
Phone: (404) 639-4330
E-mail: zgf6@cdc.gov
Submission Date: December 14, 2021
Table of Contents and Attachments
Non-Substantive Change Request Justification Document
Description of Changes (Attachment #1)
Cross-Walk 2021 to 2022 (Attachment #2)
HAIC: Multi-site Gram-Negative Surveillance Initiative (MuGSI-CRE/CRAB) (Attachment #3)
HAIC: Multi-site Gram-Negative Surveillance Initiative ─ Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI-ESBL) (Attachment #4)
Justification for Change Request for OMB 0920-0978
This is a nonmaterial/non-substantive change request for OMB No. 0920-0978, expiration date 04/30/2022, for the Emerging Infections Programs (EIP). All requested changes represent minor modifications to already-approved instruments including revised formatting, rewording, new answer options, and the addition/subtraction of a limited number of questions. Larger changes are being packaged together into a revision ICR that will be submitted later. This request is being submitted because in the prior submission two documents were left out of the package (Attachment #3 and #4). Additionally, the burden estimates for two forms that were submitted previously were incorrectly documented in the burden table. Those changes have been indicated.
The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions, local health departments, public health and clinical laboratories, infection control professionals, and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases.
Activities of the EIPs fall into the following general categories: (1) active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.
Activities in the EIP Network in which all applicants must participate are:
Active Bacterial Core surveillance (ABCs): active population-based laboratory surveillance for invasive bacterial diseases.
Foodborne Diseases Active Surveillance Network (FoodNet): active population-based laboratory surveillance to monitor the incidence of select enteric diseases.
Influenza Hospitalization Surveillance Network (FluSurv-NET): active population-based surveillance for laboratory confirmed influenza-related hospitalizations.
Healthcare-Associated Infections-Community Interface (HAIC) surveillance: active population-based surveillance for healthcare-associated pathogens and infections.
This non-substantive change request is for changes to the disease-specific data elements for HAIC only.
The changes made to all forms under this non-substantive request will aid in improving surveillance efficiency and data quality to clarify the burden of disease and possible risk factors for disease. This information can be used to inform strategies for preventing disease and negative outcomes. Specifically, changes were made for clarification purposes, to assist data collectors in capturing data in a standardized fashion to improve accuracy. As a result of proposed changes, the estimated annualized burden is expected to decrease by 490 hours, from 39,300 to 38,810 hours. The data elements and justifications are described below.
The forms for which approval for changes are being sought include:
HAIC:
Multi-site Gram-Negative Surveillance Initiative (MuGSI-CRE/CRAB) (Attachment #3)
Multi-site Gram-Negative Surveillance Initiative ─ Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI-ESBL) (Attachment #4)
Estimated Annualized Burden Hours
The estimated annualized burden is expected to decrease by 490 hours, from 39,300 to 38,810 hours because of the changes proposed in this nonmaterial/non-substantive change request. The table rows highlighted below indicate changes. Numbers that appear in red indicate were burden was not correctly indicated in the prior nonmaterial/non-substantive change request.
The following table is updated for the entire 0920-0978 burden table. Please see the above section for the two forms that are included in this change request.
Type of Respondent |
Form Name |
No. of respondents |
No. of responses per respondent |
Avg. burden per response (in hours) |
Current
|
After Proposed Changes |
State Health Department
|
ABCs Case Report Form |
10 |
808 |
20/60 |
2697 |
2697 |
ABCs Invasive Pneumococcal Disease in Children Case Report Form |
10 |
22 |
10/60 |
37 |
37 |
|
ABCs H. influenzae Neonatal Sepsis Expanded Surveillance Form |
10 |
6 |
10/60 |
10 |
10 |
|
ABCs Severe GAS Infection Supplemental Form |
10 |
136 |
20/60 |
453 |
453 |
|
ABCs Neonatal Infection Expanded Tracking Form |
10 |
37 |
20/60 |
123 |
123 |
|
FoodNet Campylobacter |
10 |
970 |
21/60 |
3395 |
3395 |
|
FoodNet Cyclospora |
10 |
42 |
10/60 |
70 |
70 |
|
FoodNet Listeria monocytogenes |
10 |
16 |
20/60 |
53 |
53 |
|
FoodNet Salmonella |
10 |
855 |
21/60 |
2993 |
2993 |
|
FoodNet Shiga toxin producing E. coli |
10 |
290 |
20/60 |
967 |
967 |
|
FoodNet Shigella |
10 |
234 |
10/60 |
390 |
390 |
|
FoodNet Vibrio |
10 |
46 |
10/60 |
77 |
77 |
|
FoodNet Yersinia |
10 |
55 |
10/60 |
92 |
92 |
|
FoodNet Hemolytic Uremic Syndrome |
10 |
10 |
1 |
100 |
100 |
|
FoodNet Clinical Laboratory Practices and Testing Volume |
10 |
70 |
20/60 |
233 |
233 |
|
FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form |
10 |
764 |
25/60 |
2768 |
3183 |
|
FluSurv-Net Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English) |
10 |
333 |
5/60 |
278 |
278 |
FluSurv-Net Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (Spanish) |
10 |
333 |
5/60 |
278 |
278 |
|
FluSurv-Net Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults) |
10 |
333 |
5/60 |
278 |
278 |
|
FluSurv-NET Laboratory Survey |
10 |
16 |
10/60 |
38 |
26 |
|
HAIC - MuGSI Case Report Form for Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB) |
10 |
500 |
28/60 |
2333 |
2333 |
|
HAIC - MuGSI Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) |
10 |
1104 |
28/60 |
5152 |
5152 |
|
HAIC - Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form |
10 |
344
|
28/60
|
1587 |
1605 |
|
HAIC - Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form |
10 |
475
|
28/60
|
2725 |
2217 |
|
HAIC - CDI Case Report and Treatment Form |
10 |
1650 |
38/60 |
10450 |
10450 |
|
HAIC Candidemia Case Report |
10 |
200 |
30/60 |
1134 |
1134 |
|
HAIC- Annual Survey of Laboratory Testing Practices for C. difficile Infections. |
10 |
16 |
19/60 |
51 |
51 |
|
HAIC- CDI Annual Surveillance Officers Survey |
10 |
1 |
15/60 |
3 |
3 |
|
HAIC- Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey (LTCF) |
10 |
45 |
5/60 |
38 |
38 |
|
HAIC- Invasive Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplification Testing (NAAT) |
10 |
11 |
20/60 |
37 |
37 |
HAIC- Invasive Staphylococcus aureus Supplemental Surveillance Officers Survey |
10 |
1 |
10/60 |
1.7 |
1.7 |
|
HAIC- Laboratory Testing Practices for Candidemia Questionnaire |
10 |
20 |
12/60 |
37 |
40 |
|
TOTAL |
|
|
38,810
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | OMB CY 08 |
Author | wsb2 |
File Modified | 0000-00-00 |
File Created | 2021-12-17 |